Molecular genetic diagnosis for most patients started with a next-generation sequencing (NGS) panel targeting genes associated with albinism—TYR, OCA2, MC1R, MITF, SLC45A2, TYRP1, and GPR143—as the initial clinical diagnosis for all patients was albinism. Here, TYR is linked to albinism.